Dosar de subiect

Altele

Telix Pharma Increases Convertible Bond Offering to $600 Million

Primul articol: 14 apr. 2026, 18:33 | Ultima actualizare: 14 apr. 2026, 18:33 | 1 sursa | 1 articol
#pharmaceuticals#funding#investment#bonds

Mai multe surse. Mai putina manipulare.

Analiza editoriala

Bazat pe 1 sursa, 1 articol

Telix Pharma, a biopharmaceutical company, has announced an upsized convertible bond deal, now totaling $600 million. This increase from the initial offering suggests strong investor confidence in the company's prospects. Convertible bonds offer investors the option to convert the bond into equity, potentially benefiting from the company's future growth.

Articole despre acest subiect

Telix Pharma Upsizes Convertible Bond Deal to $600 Million Foto: Bloomberg
Bloomberg English Dave Sebastian 14 apr. 2026, 18:33 (acum 2 zile)

Telix Pharma Upsizes Convertible Bond Deal to $600 Million

Telix Pharmaceuticals Ltd. raised $600 million from a convertible bond deal that fetched more than expected, in a sign of strong demand for Australia’s largest such offering this year. The company’s shares fell.

Citeste pe Bloomberg →